What is the relative risk of developing skin cancer in patients taking methotrexate compared to those not taking it?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18865940
Cited by: 0

Abstract

The evidence indicates a notably increased risk of non-melanoma skin cancer among methotrexate users, highlighting the importance of skin cancer surveillance in patients undergoing treatment.

Fields of Study & Subjects

Nonmelanoma Skin Cancer Studies Chemotherapy-related skin toxicity Skin Protection and Aging

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 March 2026
Language
EN